Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

Status:
Completed

Trial end date:
2021-05-31

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with acute low back pain.

Phase 3

Navipharm Corporation